Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 8;S0085-2538(20)30508-1.
doi: 10.1016/j.kint.2020.04.030. Online ahead of print.

A Report From the Brescia Renal COVID Task Force on the Clinical Characteristics and Short-Term Outcome of Hemodialysis Patients With SARS-CoV-2 Infection

Affiliations
Free PMC article

A Report From the Brescia Renal COVID Task Force on the Clinical Characteristics and Short-Term Outcome of Hemodialysis Patients With SARS-CoV-2 Infection

Federico Alberici et al. Kidney Int. .
Free PMC article

Abstract

The SARS-CoV-2 epidemic is pressuring healthcare systems worldwide. Disease outcomes in certain subgroups of patients are still scarce, and data are needed. Therefore, we describe here the experience of four dialysis centers of the Brescia Renal COVID Task Force. During March 2020, within an overall population of 643 hemodialysis patients, SARS-CoV-2 RNA positivity was detected in 94 (15%). At disease diagnosis, 37 of the 94 (39%) patients (group 1) were managed on an outpatient basis, whereas the remaining 57 (61%) (group 2) required hospitalization. Choices regarding management strategy were made based on disease severity. In group 1, 41% received antivirals and 76% hydroxychloroquine. Eight percent died and 5% developed acute respiratory distress syndrome (ARDS). In group 2, 79% received antivirals and 77% hydroxychloroquine. Forty two percent died and 79% developed ARDS. Overall mortality rate for the entire cohort was 29%. History of ischemic cardiac disease, fever, older age (over age 70), and dyspnea at presentation were associated with the risk of developing ARDS, whereas fever, cough and a C-reactive protein higher than 50 mg/l at disease presentation were associated with the risk of death. Thus, in our population of hemodialysis patients with SARS-CoV-2 infection, we documented a wide range of disease severity. The risk of ARDS and death is significant for patients requiring hospital admission at disease diagnosis.

Keywords: COVID-19; SARS-CoV-2; hemodialysis.

Similar articles

See all similar articles

References

    1. Alberici F., Delbarba E., Manenti C. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5:580–585.
    1. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection [e-pub ahead of print]. Int Urol Nephrol.10.1007/s11255-020-02451-9. Accessed April 13, 2020. - DOI
    1. Wang R, Liao C, He H, et al. COVID-19 in hemodialysis patients: a report of 5 cases [e-pub ahead of print]. Am J Kidney Dis.10.1053/j.ajkd.2020.03.009. Accessed April 12, 2020. - DOI
    1. Burgner A, Ikizler TA, Dwyer JP. COVID-19 and the inpatient dialysis unit: managing resources during contingency planning pre-crisis [e-pub ahead of print]. Clin J Am Soc Nephrol.10.2215/CJN.03750320. Accessed April 13, 2020. - DOI
    1. The Novel Coronavirus Pneumoniae Emergency Response Epidemiology Team . 2020. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Disease (COVID-19)—China. [press release]. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Accessed March 22, 2020.

LinkOut - more resources

Feedback